References
- Brodersen J. How to conduct research on overdiagnosis: a keynote paper from the EGPRN May 2016, Tel Aviv. Eur J Gen Pract 2017; 23: 78-82.
- Welch HG, Schwartz L, Woloshin S. Overdiagnosed: making people sick in the pursuit of health. Boston: Beacon Press, 2011.
- Carter SM, Rogers W, Heath I, Degeling C, Doust J, Barratt A. The challenge of overdiagnosis begins with its definition. BMJ 2015; 350: h869.
- Hansson A, Brodersen J, Reventlow S, Pettersson M. Opening Pandora’s box: the experiences of having an asymptomatic aortic aneurysm under surveillance. Health Risk Soc 2012; 14: 341-59.
- Brodersen J, Thorsen H, Kreiner S. Consequences of screening in lung cancer: development and dimensionality of a questionnaire. Value Health 2010; 13: 601-12.
- Brodersen J, Siersma VD. Long-term psychosocial consequences of false-positive screening mammography. Ann Fam Med 2013; 11: 106- 15.
- Carter JL, Coletti RJ, Harris RP. Quantifying and monitoring overdiagnosis in cancer screening: a systematic review of methods. BMJ 2015;3 50: g7773.
- Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V et al. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 2009; 360: 1320-8.
- Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V et al. Prostate-cancer mortality at 11 years of follow-up. N Engl J Med 2012; 366: 981-90.
- Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Zappa M, Nelen V et al. Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up. Lancet 2014; 384: 2027-35.
- Harris RP, Sheridan SL, Lewis CL, Barclay C, Vu MB, Kistler CE et al. The harms of screening: a proposed taxonomy and application to lung cancer screening. JAMA Intern Med 2014; 174: 281-5.
- Jessen LKH, Harris R, Brodersen J. Consequences of overdiagnosis. Preventing Overdiagnosis 2016. 3rd International Conference, Washington DC, 2015.
- Heleno B, Thomsen MF, Rodrigues DS, J⊘rgensen KJ, Brodersen J. Quantification of harms in cancer screening trials: literature review. BMJ 2013; 347: f5334.
- Preveting overdiagnosis. Available Mar 2017, from: http://www.preventingoverdiagnosis.net/.